Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-021548

Chief Business Development Off sold 1,354 shares at an average $41.69 ($56,451)

  • Chief Business Development Off acquired 1,354 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Exercise or conversion : show line 1 in the form +1,354 $31.71 $42,935 24,248 D
2021-03-15 Sale : show line 2 in the form −340 $41.22 $14,015 23,908 D
2021-03-15 Sale : show line 3 in the form −1,014 $41.85 $42,436 22,894 D
Open-market sales · 1,354 sh · avg $41.69 · $56,451

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-15 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −1,354 47,396 D
Loading xslF345X03/doc4.xml…